Clinical trial
A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects
NCT05955027 is registered in ClinicalTrials.gov with Nanjing Zenshine Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects
- Lead sponsor
- Nanjing Zenshine Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 8, 2023
- Completion date
- December 15, 2023
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.